Christopher B. Prentiss, Chief Financial Officer at Adamas Pharmaceuticals Inc (ADMS), sold 2,050 shares at $3.21 ($7K) on 2020-11-02, disclosed to the SEC on 2020-11-02.
Open-market sale of $7k ADMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ADMS | SELL | 2021-01-22 | $12K | — | Filing → |
| ADMS | SELL | 2020-01-23 | $8K | — | Filing → |
| ADMS | SELL | 2019-07-23 | $6K | — | Filing → |